Article
Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.
Trials - 30 Jun 2016
de Greef Bianca T A, Merkies Ingemar S J, Geerts Margot, Faber Catharina G, Hoeijmakers Janneke G J
Abstract excerpt
BACKGROUND: Small fiber neuropathy generally leads to considerable pain and autonomic symptoms. Gain-of-function mutations in the SCN9A- gene, which codes for the Nav1.7 voltage-gated sodium channel, have been reported in small fiber neuropathy, suggesting an underlying genetic basis in a subset of patients. Currently available sodium channel blockers lack selectivity, leading to cardiac and central nervous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
